Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians
Conditions
Liver Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novo Nordisk Investigational site, Beijing, China
Study leads
Clinical Transparency (dept. 2834)
Study Director
Novo Nordisk A/S